10x Genomics TXG
$51.80 −$5.58 (-9.72%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $51.01 -1.53%
Open$55.77
Prev close$57.38
Day range$51.30 – $56.44
Volume3.23M
Market cap$6.81B
P/E (TTM)–
Dividend yield–
TXG Stock News
Headlines matching 10x Genomics or the TXG ticker, most recent first.
- William Blair Maintains 10x Genomics(TXG.US) With Buy Rating
- Leerink Partners Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $90 Positive
- RBC Capital Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $70 Positive
- A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $50 to $53
- Citi Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $50 Positive
- J.P. Morgan Remains a Hold on 10x Genomics (TXG)
- CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $60 Positive
- Citi Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $45 Positive
- TD Cowen Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $47 Positive
- CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $50 Positive
- Piper Sandler Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $42 Positive
- Barclays Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $40 Positive
- CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Maintains Target Price $32
- A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $23 to $32
- BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Maintains Target Price $30
No comments yet — be the first to weigh in on TXG.
Sign in to join the discussion.